The latter may lead to integrated actions, which promote macrophage recruitment, increasing synthesis of pro-inflammatory mediators (e.g. leptin) and anti-inflammatory cytokines, exacerbating local inflammation and inducing tissue repair in the tumour microenvironment, respectively [19,71,72]. The gene discussed is LEP; the disease is neoplasm.